W-17: A Digital Health Platform to Create Personalized Care Experiences for Patients with Chronic Disease
Poster Presenter
Jyotsna Mehta
Founder
KEVA Health United States
Objectives
Digital technologies are increasingly used to optimize chronic disease management, however, applications to improve asthma management are limited. Suboptimal management contributes to $56 billion annual costs (direct healthcare costs plus lost school and work days) and causes ~3000 deaths/year.
ORAL PRESENTATION: 1:10PM
Method
METHODS : The mobile app-based solution, driven by a decision support engine, was custom-developed as a generic disease management platform, and prototype was populated with a set of evidence-based asthma-specific rules and tested with a QC process. Surveys,focus groups and patient testing was done.
Results
The automated solution pushes notifications reminding patients to track their symptoms and peak flow measurements, take medications, and complete health care maintenance and educational tasks. Of the 50 clinicians surveyed, 86% said ‘Improving adherence could reduce costs’ and 94% said ‘I would recommend such an app to my patients’. Patient focus groups resulted in adding improvements including a feature for patients in duress. Real world patient testing showed high levels of initial engagement. Engagement appropriately dropped off once symptoms were controlled and preventative tasks on to-do lists were completed. Patients re-engaged right away when symptoms flared, enabling early, proactive steps to be taken to avoid further deterioration.
Conclusion
We created a digital app with a simple interface to engage patients, providing 24/7 physician support, and real time clinical guidance to resolve routine issues independently. Digital health solutions can help with patient engagement, product launch and commercialization. Future work will aim for interventions and applications in various therapeutic areas for outcomes research, PRO and RWE assessment
